Ironwood Pharmaceuticals, Inc. - IRWD - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Ironwood Pharmaceuticals, Inc. - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
IRWD	Nasdaq	8731	http://www.ironwoodpharma.com/	12.43 +0.53
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Ironwood Pharmaceuticals, Inc. Almirall CEO Eyes $11.6 Billion COPD Market Smokers Fuel - Jun 18th, 2013 4:01 pm IRWD Launches Constella in Europe - Jun 17th, 2013 3:50 pm Synergy Pharma rises as analyst starts coverage - Jun 17th, 2013 1:22 pm Synergy Pharma rises as analyst starts coverage - Jun 17th, 2013 1:22 pm Constella® (linaclotide), the first approved prescription therapy in a new class of treatments for adults with IBS-C, is now available in Europe - Jun 13th, 2013 8:46 am 4 Stocks Underperforming Today In The Health Services Industry - Jun 12th, 2013 11:04 am IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement - Jun 11th, 2013 11:01 pm IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - Jun 5th, 2013 4:31 am Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters’ Option in Public Offering of Common Stock - Jun 4th, 2013 2:00 pm Ironwood Pharmaceuticals, Inc. - Shareholder/Analyst Call - Jun 4th, 2013 8:30 am Movers roundup: Facebook, Michael Kors - May 30th, 2013 12:46 pm Movers roundup: Facebook, Michael Kors - May 30th, 2013 12:46 pm Ironwood Pharma rises following analyst upgrade - May 30th, 2013 11:42 am Ironwood Pharma rises following analyst upgrade - May 30th, 2013 11:42 am Ironwood Pharmaceuticals (IRWD) Shares Cross Above 200 DMA - May 30th, 2013 9:50 am 3 Horrendous Health-Care Stocks This Week - May 25th, 2013 8:10 am Positive Data from Synergy Pharma - May 24th, 2013 9:05 am IRONWOOD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 24th, 2013 2:32 am Ironwood Pharma Prices Stock Offering - May 23rd, 2013 9:35 am Grab IRWD Even Cheaper Than Its Secondary? - May 23rd, 2013 8:08 am View All Current Headlines >>